ATE293113T1 - Neue polymorphe formen von olanzapin - Google Patents
Neue polymorphe formen von olanzapinInfo
- Publication number
- ATE293113T1 ATE293113T1 AT00983422T AT00983422T ATE293113T1 AT E293113 T1 ATE293113 T1 AT E293113T1 AT 00983422 T AT00983422 T AT 00983422T AT 00983422 T AT00983422 T AT 00983422T AT E293113 T1 ATE293113 T1 AT E293113T1
- Authority
- AT
- Austria
- Prior art keywords
- olazapine
- polymorphous forms
- new
- new polymorphous
- forms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN977BO1999 IN187439B (de) | 2000-03-31 | 1999-12-28 | |
| US09/540,749 US6348458B1 (en) | 1999-12-28 | 2000-03-31 | Polymorphic forms of olanzapine |
| PCT/GB2000/004982 WO2001047933A1 (en) | 1999-12-28 | 2000-12-22 | New polymorphic forms of olanzapine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE293113T1 true ATE293113T1 (de) | 2005-04-15 |
Family
ID=26324183
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00983422T ATE293113T1 (de) | 1999-12-28 | 2000-12-22 | Neue polymorphe formen von olanzapin |
| AT0046403U AT6739U1 (de) | 1999-12-28 | 2003-07-02 | Neue polymorphe formen des olanzapins |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT0046403U AT6739U1 (de) | 1999-12-28 | 2003-07-02 | Neue polymorphe formen des olanzapins |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1246827B1 (de) |
| AT (2) | ATE293113T1 (de) |
| AU (1) | AU779452B2 (de) |
| CA (1) | CA2395774C (de) |
| DE (1) | DE60019461T2 (de) |
| DK (2) | DK1246827T3 (de) |
| ES (1) | ES2240215T3 (de) |
| NZ (1) | NZ519926A (de) |
| PT (1) | PT1246827E (de) |
| WO (1) | WO2001047933A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4530664B2 (ja) * | 2001-12-24 | 2010-08-25 | サン・ファーマシューティカル・インダストリーズ・リミテッド | ２−メチル−４−（４−メチル−１−ピペラジニル）−１０Ｈ−チエノ［２，３−ｂ］［１，５］ベンゾジアゼピンの結晶形Ｉ、この結晶形Ｉの製造方法、及び医薬組成物 |
| AU2003237305A1 (en) | 2002-05-31 | 2003-12-19 | Geneva Pharmaceuticals, Inc. | Process of preparation of olanzapine form i |
| SI21270A (sl) * | 2002-07-15 | 2004-02-29 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Kristalne oblike olanzapina in postopki za njihovo pripravo |
| ATE504588T1 (de) | 2004-01-27 | 2011-04-15 | Synthon Bv | Stabile salze von olanzapin |
| AR047461A1 (es) * | 2004-01-27 | 2006-01-18 | Synthon Bv | Formacion, purificacion y uso de n-formilolanzapina |
| PL381564A1 (pl) | 2007-01-22 | 2008-08-04 | Koźluk Tomasz Nobilus Ent | Sposób wytwarzania zasadniczo czystej odmiany polimorficznej I olanzapiny |
| EP2486913A1 (de) | 2011-02-14 | 2012-08-15 | Labtec GmbH | Orale Filmformulierungen für Olanzapin mit schneller Zersetzung |
| CN110964035A (zh) * | 2019-12-06 | 2020-04-07 | 北大医药股份有限公司 | 一种将奥氮平母液进行清洁回收的工业化方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CR5278A (es) * | 1995-03-24 | 1996-07-04 | Lilly Co Eli | Formulacion oral de 2-metil-tieno-benzodiacepina |
| EG23659A (en) * | 1995-03-24 | 2007-03-26 | Lilly Co Eli | Process and crystal forms of methyl-thieno-benzodiazepine |
| NZ334346A (en) * | 1996-09-23 | 2000-05-26 | Lilly Co Eli | Olanzapine dihydrate D comprising 2-methyl-4-(4-methyl-1-piperazinyl)-1OH-thieno[2,3-b][1,5]benzodiazepine and a formulation for use in treating central nervous system disorders |
| CN1146422C (zh) * | 1998-09-30 | 2004-04-21 | 伊莱利利公司 | 2-甲基-噻吩并-苯并二氮杂�制剂 |
-
2000
- 2000-12-22 AT AT00983422T patent/ATE293113T1/de not_active IP Right Cessation
- 2000-12-22 WO PCT/GB2000/004982 patent/WO2001047933A1/en active IP Right Grant
- 2000-12-22 AU AU20176/01A patent/AU779452B2/en not_active Ceased
- 2000-12-22 DK DK00983422T patent/DK1246827T3/da active
- 2000-12-22 ES ES00983422T patent/ES2240215T3/es not_active Expired - Lifetime
- 2000-12-22 EP EP00983422A patent/EP1246827B1/de not_active Expired - Lifetime
- 2000-12-22 DE DE60019461T patent/DE60019461T2/de not_active Expired - Lifetime
- 2000-12-22 NZ NZ519926A patent/NZ519926A/en not_active IP Right Cessation
- 2000-12-22 CA CA002395774A patent/CA2395774C/en not_active Expired - Fee Related
- 2000-12-22 PT PT00983422T patent/PT1246827E/pt unknown
-
2003
- 2003-06-16 DK DK200300161U patent/DK200300161U3/da active
- 2003-07-02 AT AT0046403U patent/AT6739U1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AT6739U1 (de) | 2004-03-25 |
| DE60019461T2 (de) | 2005-09-22 |
| EP1246827B1 (de) | 2005-04-13 |
| EP1246827A1 (de) | 2002-10-09 |
| CA2395774C (en) | 2009-09-15 |
| DK200300161U3 (da) | 2003-12-12 |
| ES2240215T3 (es) | 2005-10-16 |
| AU2017601A (en) | 2001-07-09 |
| WO2001047933A1 (en) | 2001-07-05 |
| PT1246827E (pt) | 2005-08-31 |
| NZ519926A (en) | 2004-02-27 |
| DK1246827T3 (da) | 2005-05-23 |
| CA2395774A1 (en) | 2001-07-05 |
| DK200300161U1 (da) | 2003-06-16 |
| DE60019461D1 (de) | 2005-05-19 |
| AU779452B2 (en) | 2005-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE222256T1 (de) | Polymorphe form von clopidogrel-hydrogenosulfat | |
| DE69936760D1 (de) | Neue Amylasen | |
| DE60015796D1 (de) | Neue aminopropylphosphinsäuren | |
| DE60228345D1 (de) | Neue Kristallforme von Azithromycin | |
| ATE246674T1 (de) | Neue 3-aryl-2-hydroxypropionsäure-derivate | |
| DE69911770D1 (de) | Neue 3-aryl-propionsäurederivate und analoge | |
| ATE271031T1 (de) | Neue phenylpropargyletherderivate | |
| ATE261964T1 (de) | Neue antiarrhytmische bispidin-verbindungen | |
| ATE355264T1 (de) | Neue aryloxy-alkyl-dialkylamine | |
| ATE437871T1 (de) | Polymorphe formen von 1-ä4-(5-cyanoindol-3- yl)butylü-4-(2-carbamoylbenzofuran-5-yl) piperazin-hydrochlorid | |
| DE69733933D1 (de) | Neue Liganden des Neuropeptide Rezeptors HFGAN72 | |
| ATE231521T1 (de) | Kristalline formen von eto2c-ch2-(r)cgl-aze-pab- oh | |
| DE69932920D1 (de) | Neue dihydroxyhexansäurederivate | |
| DE69836697D1 (de) | Neue 3,6-Hemiketale der 9a-Azalidklasse | |
| ATE293113T1 (de) | Neue polymorphe formen von olanzapin | |
| DE60111268D1 (de) | Neue pleuromutilinderivate | |
| DE60103033D1 (de) | Neue phenylheteroalkylamin-derivate | |
| ID22326A (id) | Struktur montasi sarung garpu | |
| DE69802923D1 (de) | neue tetrahydroiosoquinolin thiophenecarboximidamiden | |
| DE69718527D1 (de) | Neue Hexokinase | |
| DE60007360T2 (de) | Amorphe modifikation von torasemid | |
| DE69705405D1 (de) | Neue formen der organischen salze des n'n-diacetylcystins | |
| ID23099A (id) | Alat penahan posisi badan ritsleting | |
| DE59907066D1 (de) | Gummituch | |
| DE29817757U1 (de) | Multifunktioneller Schuhlöffel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1246827 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |